Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial)

Clinical trial NCT02092532 · UNKNOWN

Trial details

NCT number

NCT02092532

Sponsor

Southeast Retina Center, Georgia

Status

UNKNOWN

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2014-03-01

Primary completion

2015-03-01

Enrollment

20

View on ClinicalTrials.gov